Sequoia Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Buy |
40,748
+2,293
| +6% | +$246K | 0.03% | 304 |
|
|
2025
Q1 | $3.88M | Buy |
38,455
+8,184
| +27% | +$826K | 0.03% | 307 |
|
|
2024
Q4 | $2.7M | Buy |
30,271
+3,879
| +15% | +$346K | 0.03% | 350 |
|
|
2024
Q3 | $2.21M | Buy |
26,392
+97
| +0.4% | +$8.13K | 0.02% | 358 |
|
|
2024
Q2 | $2.02M | Buy |
26,295
+1,661
| +7% | +$128K | 0.02% | 320 |
|
|
2024
Q1 | $1.69M | Sell |
24,634
-5,560
| -18% | -$381K | 0.02% | 358 |
|
|
2023
Q4 | $1.75M | Buy |
30,194
+11,925
| +65% | +$689K | 0.02% | 386 |
|
|
2023
Q3 | $965K | Buy |
18,269
+934
| +5% | +$49.3K | 0.02% | 345 |
|
|
2023
Q2 | $938K | Buy |
17,335
+998
| +6% | +$54K | 0.02% | 359 |
|
|
2023
Q1 | $817K | Buy |
16,337
+1,575
| +11% | +$78.8K | 0.02% | 356 |
|
|
2022
Q4 | $683K | Buy |
14,762
+8,426
| +133% | +$390K | 0.02% | 370 |
|
|
2022
Q3 | $245K | Buy |
+6,336
| New | +$245K | 0.01% | 445 |
|
|
2022
Q2 | – | Sell |
-5,204
| Closed | -$230K | – | 605 |
|
|
2022
Q1 | $230K | Buy |
+5,204
| New | +$230K | 0.01% | 577 |
|